Polina Sysa‐Shah
Impact in
-
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
- Behavioral Neuroscience top 5%
Papers in
-
- Cardiomyopathy and Myosin Studies 5
- Chemotherapy-induced cardiotoxicity and mitigation 3
- Co-authors
- Martin G. PomperWojciech G. LesniakRobert F. DannalsWilliam B. MathewsJuan L. GomezJordi BonaventuraAntonello BonciBrandon K. Harvey
- Journals
- Oncotarget (3 papers)PLoS ONE (2 papers)Molecular Cancer Therapeutics (1 paper)Biotechnology Letters (1 paper)Cardiovascular Research (1 paper)
- Partner nations
- United StatesJapanDenmark
In The Last Decade
Polina Sysa‐Shah
25 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Cellular and Molecular Neuroscience 464
- Behavioral Neuroscience 74
- Endocrine and Autonomic Systems 124
- Cognitive Neuroscience 274
- Molecular Biology 738
Countries citing papers authored by Polina Sysa‐Shah
This map shows the geographic impact of Polina Sysa‐Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Polina Sysa‐Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Polina Sysa‐Shah more than expected).
Fields of papers citing papers by Polina Sysa‐Shah
This network shows the impact of papers produced by Polina Sysa‐Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Polina Sysa‐Shah. The network helps show where Polina Sysa‐Shah may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Polina Sysa‐Shah, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2022 | 0 | |
| 4 | 2021 | 3 | |
| 5 | 2020 | 17 | |
| 6 | 2019 | 89 | |
| 7 | 2018 | 103 | |
| 8 | 2018 | 13 | |
| 9 | Chemogenetics revealed: DREADD occupancy and activation via converted clozapine Hit paper breakdown → | 2017 | 677 |
| 10 | Echocardiographic Characterization of a Murine Model of Hypertrophic Obstructive Cardiomyopathy Induced by Cardiac-specific Overexpression of Epidermal Growth Factor Receptor 2. | 2016 | 13 |
| 11 | 2016 | 3 | |
| 12 | 2016 | 47 | |
| 13 | 2015 | 37 | |
| 14 | Electrocardiographic Characterization of Cardiac Hypertrophy in Mice that Overexpress the ErbB2 Receptor Tyrosine Kinase. | 2015 | 21 |
| 15 | 2015 | 42 | |
| 16 | 2014 | 2 | |
| 17 | 2014 | 356 | |
| 18 | 2014 | 12 | |
| 19 | 2013 | 17 | |
| 20 | 2012 | 49 |
About Polina Sysa‐Shah
Polina Sysa‐Shah is a scholar working on Developmental Neuroscience, Cardiology and Cardiovascular Medicine, Oncology, Physiology and Virology, having authored 26 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cardiomyopathy and Myosin Studies (5 papers), HER2/EGFR in Cancer Research (3 papers), Enzyme function and inhibition (3 papers), CAR-T cell therapy research (3 papers), Birth, Development, and Health (3 papers), Receptor Mechanisms and Signaling (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (464 citations), Behavioral Neuroscience (74 citations), Endocrine and Autonomic Systems (124 citations), Cognitive Neuroscience (274 citations) and Molecular Biology (738 citations). Polina Sysa‐Shah has collaborated with scholars based in United States, Japan and Denmark. Frequent co-authors include Martin G. Pomper, Wojciech G. Lesniak, Robert F. Dannals, William B. Mathews, Juan L. Gomez, Jordi Bonaventura, Antonello Bonci, Brandon K. Harvey, Michael Michaelides and Randall J. Ellis. Their work appears in journals such as Oncotarget, PLoS ONE, Molecular Cancer Therapeutics, Biotechnology Letters and Cardiovascular Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.